Agency / Source: Bruker Corporation

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Bruker Showcases High-Performance Solutions at Analytica 2024 for Research and Analysis in Applied, Industrial and Biopharma Laboratories - Bruker Corporation, is showcasing some of its latest innovations at Analytica 2024 - Bruker.com
Bruker Showcases High-Performance Solutions at Analytica 2024 for Research and Analysis in Applied, Industrial and Biopharma Laboratories

 

PRZOOM - /newswire/ - Munich, Bavaria, Germany, 2024/04/09 - Bruker Corporation, is showcasing some of its latest innovations at Analytica 2024 - Bruker.com. NASDAQ: BRKR

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Applied and Industrial Markets Solutions

The new EVOQ DART-TQ⁺ mass spectrometer simplifies high-throughput testing with its integrated DART ion source, eliminating the need for upfront chromatography. With a 20-second analysis time per sample, it provides a fast solution for routine food and environmental testing. By bypassing traditional chromatography methods, it enhances productivity and uptime while lowering cost of ownership. It offers a quick switch to LC-MS for conventional water and food testing.

The ecTOF is a novel GC-HRMS that records EI and CI spectral data in one GC run. It combines parent ion data (via soft CI) and NIST-searchable fragment ion spectra (70 eV EI) to reduce false positives and identify unknown compounds in complex samples. The ecTOF also improves analysis speed, instrument uptime, and expedites data post-processing. This elevates the analysis of complex samples in targeted, suspect, and non-targeted GC-HRMS.

The new BEAM FT-NIR uses Bruker’s RockSolid™ interferometer for accuracy and stability. Designed for quality control, it is IP65-protected and suitable for solid and semi-solid materials, and can be fitted on pipelines, hoppers, or conveyor belts. The BEAM improves manufacturing process control and minimizes variations. Its single-point FT-NIR process analyzer allows quick analysis in process environments, ensuring long-term stability for minimizing waste and rework.

The D6 PHASER makes advanced XRD methods accessible for cleantech markets. Dr. Jan Vos, Researcher at Magneto Special Anodes, stated: “We are heavily invested in the development of electrocatalytic coatings that will form the beating heart of the next generation of water electrolyzers in the green energy transition. Bruker's D6 PHASER provide us with the extraordinary power, flexibility, and accuracy needed to push our coating development forward. We will have access to advanced X-ray techniques crucial for material science that were previously not available in a compact benchtop system.”

The Fourier 80 X-optimized 1H/7Li system facilitates battery research by examining lithium-based materials essential for better batteries. Dr. Vick Singh, Director of Research & Development for Dragonfly Energy, stated "As we transition from fundamental materials development towards implementing new materials in prototypes and pilot lines, benchtop systems with lithium NMR can be a great tool.” The collaboration between Bruker and Dragonfly Energy accelerates pioneering battery technology research, showcasing the versatility of the Fourier 80 benchtop FT-NMR platform.

Bruker’s Avance Chemical Profiling Module for NMR, provides data processing, interpretation, and reporting, improving quality and efficiency in diverse QC processes. It simplifies NMR analysis, offering a tool to identify and quantify various compounds in a mixture with a single measurement. Its user-friendly interface and driven workflow make it a practical NMR solution for routine analysis in manufacturing settings.

Bruker presents the MGA series, a laser-based gas analyzer from MIRO Analytical AG to simultaneously measure various pollutants and greenhouse gases with high precision. It can detect gases such as CO, NO, NO2, NH3, O3, SO2, CO2, CH4, and N2O. Its compact size and rapid measurements are suitable for mobile monitoring. Its Quantum Cascade Lasers enable precise gas detection, contributing to our understanding of air pollution.

Gracing Incidence X-ray Fluorescence (GIXRF) for the S4 T-STAR® excites a flat sample by changing the beam angle. The resulting signal profiles vary based on sample type, mass and thickness. GIXRF offers non-destructive material analysis with a compact benchtop TXRF spectrometer, used for quick qualitative assessments of structures such as nanoparticles, monolayers, or layered systems. This enables the monitoring of diffusion in multilayer systems and the study of metal dopant depth profiles in substrates.

BioPharma Solutions

The Fourier 80 benchtop FT-NMR is now equipped with the synTQ NMR PAT adapter, enhancing Process Analytical Technologies by structural insights, accurate quantification, and efficient process QC. The adapter synchronizes with soft sensors and techniques like IR and Raman, integrating data streams for thorough process understanding. The Fourier PAT is useful in distributed API manufacturing, collecting reaction data for AI-driven process optimization. This setup advances API production, supports distributed and on-demand manufacturing, and improves safety, environmental impact, and cost-effectiveness.

The new Triceratops SPR #64 enhances real-time, label-free molecular interaction characterization. Its innovative microfluidics allows 64 sensor spots, pushing the boundaries of SPR capabilities. It offers industry-leading throughput without sacrificing data quality. Its user-friendly touchscreen and automation features, including robot integration make it convenient for SPR biopharma research.

About Bruker Corporation - Leader of the Post-Genomic Era

Bruker (bruker.com) is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in post-genomic life science molecular and cell biology research, in applied and biopharma applications, in microscopy and nanoanalysis, as well as in industrial and cleantech research, and next-gen semiconductor metrology in support of AI. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics.

Investor Contact: Justin Ward - Sr. Director, Investor Relations & Corporate Development
T: +1 978-663-3660 x1479 - E: Investor.Relations[.]bruker.com.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Bruker Corporation

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Bruker Showcases High-Performance Solutions at Analytica 2024 for Research and Analysis in Applied, Industrial and Biopharma Laboratories

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
EVOQ DART-TQ+ | Bruker Corporation
Contact: Markus Ziegler - Bruker.com 
+49 172 3733531 pr[.]bruker.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Bruker Corporation securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Press Releases From Bruker Corporation / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Press Releases:

HUB Organoids B.V. Awarded Frost & Sullivan’s 2024 Technology Innovation Leadership Award for Transforming Drug Development
Immunology Consultants Laboratory Rebrand Highlights R&D and Service Specializations
Ipsen and Skyhawk Therapeutics Announce RNA Targeting Research Collaboration in Rare Neurological Diseases
Transgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer At AACR 2024
STEMCELL Technologies Announces FDA De Novo Classification for Its EasySep™ CD138 Positive Selection Kit to Support Cancer Diagnostic Tests
ONO Implements Oracle's CTMS for Global Centralized Management of Clinical Trials
BASF Aroma Ingredients Expands its Isobionics® Portfolio with New Natural Flavors
Bruker Completes Acquisition of Optical Cell Imaging Company Phasefocus
Transgene, NEC, and BostonGene Expand Collaboration for Phase I/II Clinical Trial of Neoantigen Cancer Vaccine TG4050
SCHOTT Pharma Offers Complete Testing Suite for Container Selection and Drug Submission Preparation

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
.



PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  BizJobs.com

Visit  RightITnow, Inc.







 
  ©2005-2024 PRZOOM - Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today